Insulin resistance and heart injury in rats with insulin resistance or type 2 diabetes mellitus

Acta Cardiologica

Volumn 65, Issue 3, 2010, Pages 329-335

  Yang, Zhong Hua ^a   Peng, Xiao Dong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Heart injury; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLUCOSE; HYDROXYPROLINE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC CARDIOMYOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HEART INJURY; HEART MUSCLE CELL; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; NICK END LABELING; NONHUMAN; PATHOGENESIS; RAT; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; HYDROXYPROLINE; IN SITU NICK-END LABELING; INSULIN RESISTANCE; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

EID: 77955809745     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.3.2050350     Document Type: Article

References (29)

1. Codinach Huix P, Freixa Pamias R. Diabetic cardiomyopathy: concept, heart function, and pathogenesis. An Med Interna 2002; 19: 313-20 [in Spanish].
2. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25: 543-67.
3. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
4. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974; 229: 1749-54.
5. Francis GS. Diabetic cardiomyopathy: fact or fiction? Heart 2001; 85: 247-8.
6. Konduracka E, Gackowski A, Rostoff P, Galicka-Latala D, Frasik W, Piwowarska W. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 2007; 28: 2465-71. (Pubitemid 47614285)
7. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006; 291: H1489-506.
8. Feuvray D. Diabetic cardiomyopathy. Arch Mal Coeur Vaiss 2004; 97: 261-5.
9. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-329.
10. Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989; 65: 378-87.
11. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2000; 279: E1104-13.
12. Chang-Quan H, Bi-Rong D, Qian X, Ping H, Qun-Fang D, Zhen-Chan L, Xiao-Dong P. Renal injury, abnormal vitamin D metabolism and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus. J Investig Med 2008; 56:872-7.
13. Chang-Quan H, Bi-Rong D, Ping H, Zhen-Chan L, Xiao-Dong P. Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res 2008; 39: 380-7.
14. Blaedel WJ, Uhl JM. Nature of materials in serum that interfere in the glucose oxidase-peroxidase-0-dianisidine method for glucose, and their mode of action. Clin Chem 1975; 21: 119-24.
15. Straczkowski M, Stepien, Kowalska I, Kinalska I. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Med Sci Monit 2004; 10: CR480-4.
16. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-7.
17. Zhao XY, Hu SJ, Li J, Mou Y, Chen BP, Xia Q. Decreased cardiac sarcoplasmic reticulum Ca2 + -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats. J Physiol Biochem 2006; 62: 1-8. (Pubitemid 44102814)
18. Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA. Defective intracellular Ca(2 +) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283: H1398-408.
19. Pereira L, Matthes J, Schuster I, Valdivia HH, Herzig S, Richard S, Gómez AM. Mechanisms of [Ca2 +]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 2006; 55: 608-15.
20. Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004; 53: 3201-8.
21. Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 2002: 160: 2035-43. (Pubitemid 34663396)
22. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 48: 1688-97.
23. Shen X, Zheng S, Metreveli NS, Epstein PN. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006; 55: 798-805.
24. Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2 +-ATPase and myosin heavy chain isozyme switch. Diabetologia 2006; 49: 1434-46.
25. Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36: 1014-8.
26. Volkovová K, Chorváthová V, Jurcovicová M, Koszeghyová L, Bobek P. Antioxidative state of the myocardium and kidneys in acute diabetic rats. Physiol Res 1993; 42: 251-5. (Pubitemid 23286337)
27. Aliciguzel Y, Ozen I, Aslan M, Karayalcin U. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 2003; 142: 172-7.
28. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004; 53: 1336-43.
29. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002; 51: 1938-48. (Pubitemid 34564309)